Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

NCT02581410 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)

Sponsor

GlaxoSmithKline